« Previous
Next »
Heart, Lung and Circulation
Volume 15, Issue 5
, Pages 300-305
, October 2006
Registry Data Evaluating the Effectiveness of Drug-eluting Stents for the Treatment of Symptomatic In-stent Restenosis
References
- . Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;1:4
- A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331:489–495
- A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994;331:496–501
- A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
- A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 2003;348:1537–1545
- . Drug-eluting stents: cost versus clinical benefit. Circulation. 2003;107:3003–3007
- Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol. 1996;78:618–622
- A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol. 2003;42:796–805
- Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies. J Am Coll Cardiol. 2004;43:1964–1972
- Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation. 2002;105:583–588
- Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registry. Catheter Cardiovasc Interv. 2001;52:24–34
- Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty. J Am Coll Cardiol. 2001;38:672–679
- . Clinical trials of vascular brachytherapy for in-stent restenosis: update. Cardiovasc Radiat Med. 2001;2:107–113
- Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol. 2000;36:65–68
- Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation. 2004;109:340–344
- Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation. 1997;96:727–732
- Paclitaxel-eluting stent vs vascular brachytherapy for in-stent restenosis within bare metal stents: the TAXUS-V ISR randomized trial. JAMA. 2006;295:1253–1263
- Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare metal stents: the SISR randomized trial. JAMA. 2006;295:1307–1309
- Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation. 2005;111:2107–2111
- Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol. 2003;41:184–189
- TAXUS III trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation. 2003;107:559–564
- Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Heart. 2004;90:1183–1188
- Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis. Catheter Cardiovasc Interv. 2005;64:28–34
- Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005;293:165–171
- . Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):576S–599S
- Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872–1878
- . Coronary restenosis: a review of mechanisms and management. Am J Med. 2003;115:547–553
- Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation. 2004;110:3627–3635
- Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: short- and long-term results. Am Heart J. 2001;141:610–614
- . Clinical and angiographic follow-up after balloon angioplasty with provisional stenting for coronary in-stent restenosis. Catheter Cardiovasc Interv. 1999;48:151–156
- Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med. 2005;353:653–662
- Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation. 2005;111:321–327
- Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J Am Coll Cardiol. 2005;45:1193–1200
- . Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near Gaussian distribution: a quantitative angiographic study in 1445 successfully dilated lesions. J Am Coll Cardiol. 1992;19:939–945
- . Defining coronary restenosis: newer clinical and angiographic paradigms. Circulation. 1993;88:1310–1323
PII: S1443-9506(06)00128-4
doi: 10.1016/j.hlc.2006.06.002
© 2006 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Heart, Lung and Circulation
Volume 15, Issue 5
, Pages 300-305
, October 2006
